India to United States: Sirolimus Export Trade Route
India has recorded 123 verified shipments of Sirolimus exported to United States, representing a combined trade value of $12.3M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $99.8K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED, which accounts for 36% of total export value with 23 shipments worth $4.5M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $6.1M USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, ALKEM LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED — together control 76% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Sirolimus corridor is one of India's established pharmaceutical export routes, with 123 shipments documented worth a combined $12.3M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's sirolimus manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $99.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #2 among India's top sirolimus export destinations globally.
On the import side, key buyers of Indian sirolimus in United States include EVERSANA LIFE SCIENCE SERVICES, ASCEND LABORATORIES,LLC, DR REDDYS LABORATORIES INC and 16 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 28 shipments valued at $6.1M USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portAHEMDABAD AIR
Market Position
- Global rank#2
- Annual growth+27.4%
- Demand growth+24.9%
- Regulatory ease65/100
Top 10 Indian Sirolimus Exporters to United States
Showing top 10 of 14 Indian suppliers exporting Sirolimus to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED Avg $194.1K per shipment | 23 | $4.5M | 36.4% |
| 2 | ALKEM LABORATORIES LIMITED Avg $103.2K per shipment | 31 | $3.2M | 26.1% |
| 3 | CADILA HEALTHCARE LIMITED Avg $328.2K per shipment | 5 | $1.6M | 13.4% |
| 4 | DR REDDYS LABORATORIES LIMITED Avg $176.9K per shipment | 8 | $1.4M | 11.5% |
| 5 | DR REDDY S LABORATORIES LIMITED Avg $177.1K per shipment | 4 | $708.6K | 5.8% |
| 6 | ALKEM LABORATORIES LTD Avg $67.0K per shipment | 4 | $268.1K | 2.2% |
| 7 | GLENMARK PHARMACEUTICALS LIMITED Avg $35.7K per shipment | 6 | $214.2K | 1.7% |
| 8 | CONCORD BIOTECH LTD Avg $14.9K per shipment | 12 | $178.3K | 1.5% |
| 9 | INTAS PHARMACEUTICALS LIMITED Avg $82.5K per shipment | 2 | $165.0K | 1.3% |
| 10 | ANNORA PHARMA PRIVATE LIMITED Avg $19.4K per shipment | 1 | $19.4K | 0.2% |
This table shows the top 10 of 14 Indian companies exporting sirolimus to United States, ranked by total trade value. The listed exporters are: ZYDUS LIFESCIENCES LIMITED, ALKEM LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED, DR REDDYS LABORATORIES LIMITED, DR REDDY S LABORATORIES LIMITED, ALKEM LABORATORIES LTD, GLENMARK PHARMACEUTICALS LIMITED, CONCORD BIOTECH LTD, INTAS PHARMACEUTICALS LIMITED, ANNORA PHARMA PRIVATE LIMITED. ZYDUS LIFESCIENCES LIMITED is the dominant supplier with 23 shipments worth $4.5M USD, giving it a 36% market share. The top 3 suppliers together account for 76% of the total trade value on this route.
Showing top 10 of 14 total Indian exporters on the India to United States Sirolimus export route.
Top 10 Sirolimus Importers in United States
Showing top 10 of 19 known buyers in United States receiving Sirolimus shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sirolimus in United States include EVERSANA LIFE SCIENCE SERVICES, ASCEND LABORATORIES,LLC, DR REDDYS LABORATORIES INC, ASCEND LABORATORIES LLC, XX RXXDYSXXABOXXTORXXS IXX, among 19 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $6.1M USD across 28 shipments — representing 50% of all sirolimus imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 28 | $6.1M | 49.7% |
| 2 | ASCEND LABORATORIES,LLC | 21 | $2.7M | 21.9% |
| 3 | DR REDDYS LABORATORIES INC | 7 | $1.2M | 10.2% |
| 4 | ASCEND LABORATORIES LLC | 11 | $646.6K | 5.3% |
| 5 | XX RXXDYSXXABOXXTORXXS IXX | 3 | $540.8K | 4.4% |
| 6 | Small Animal Clinical Services | 12 | $178.3K | 1.5% |
| 7 | XX RXXDY XXLABXXATOXXES XXC | 1 | $167.8K | 1.4% |
| 8 | DR REDDY S LABORATORIES INC | 1 | $167.6K | 1.4% |
| 9 | EVERSANA LIFE SCIENCES SERVICESLLC | 2 | $165.0K | 1.3% |
| 10 | GLENMARK PHARMACEUTICALS INC | 4 | $156.9K | 1.3% |
Showing top 10 of 19 Sirolimus importers in United States on this route.
Top 10 Sirolimus Formulations Imported by United States
Showing top 10 of 75 product formulations shipped on the India to United States Sirolimus route, ranked by trade value
United States imports a wide range of sirolimus formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SIROLIMUS TABLETS 0.5 MG - 1 X 100 — accounts for $2.1M USD across 3 shipments. There are 75 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SIROLIMUS TABLETS 0.5 MG - 1 X 100 | 3 | $2.1M | 17.5% |
| 2 | PHARMA : SIROLIMUS TABLETS 0.5MG (SIROLI | 1 | $1.4M | 11.3% |
| 3 | SIROLIMUS TABLETS 0.5 MG - 1 X 100TBS | 6 | $1.0M | 8.2% |
| 4 | PHARMACEUTICAL PRODUCTS : SIROLIMUS TABLETS 0.5MG (100'S) USA NDC No67877074601 | 3 | $578.3K | 4.7% |
| 5 | PHARMACEUTICAL PRODUCTS : SIROLIMUS TABLETS 1MG (100'S) USA NDC No67877074701 | 5 | $543.9K | 4.4% |
| 6 | SIROLIMUS TABS 1MG,USA HDPE 100S | 3 | $539.9K | 4.4% |
| 7 | PHARMACEUTICAL PRODUCTS : SIROLIMUS TABLETS 2MG (100'S) USA NDC No67877074801 | 2 | $452.6K | 3.7% |
| 8 | SIROLIMUS TABS 1MG USA HDPE 100S | 2 | $450.8K | 3.7% |
| 9 | SIROLIMUS TABS 1MGUSA HDPE 100S | 2 | $450.6K | 3.7% |
| 10 | SIROLIMUS TABLETS 0.5MG (100'S) USA NDC NO67877074601 | 2 | $345.3K | 2.8% |
Showing top 10 of 75 Sirolimus formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
AHEMDABAD AIR handles the highest volume with 25 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's sirolimus exports to United States are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, ALKEM LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED — together account for 76% of total trade value on this route. The average shipment value of $99.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma : sirolimus tablets 0.5mg (siroli and sirolimus tablets 0.5 mg - 1 x 100tbs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 28 shipments worth $6.1M USD — representing 50% of all sirolimus imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $12.3M
- Avg. Shipment
- $99.8K
- Suppliers
- 14
- Buyers
- 19
- Transit (Sea)
- ~19 days
- Annual Growth
- +27.4%
Reverse Direction
United States → India — Sirolimus (Import)Other Sirolimus Routes
Unlock the Full India to United States Sirolimus Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 123 shipments on this route.
Frequently Asked Questions — India to United States Sirolimus Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sirolimus to United States?
The leading Indian exporters of Sirolimus to United States are ZYDUS LIFESCIENCES LIMITED, ALKEM LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED. ZYDUS LIFESCIENCES LIMITED holds the largest market share at approximately 36% of total trade value on this route.
Q What is the total value of Sirolimus exports from India to United States?
India exports Sirolimus to United States worth approximately $12.3M USD across 123 recorded shipments. The average value per shipment is $99.8K USD.
Q Which ports does India use to ship Sirolimus to United States?
The most active port of origin is AHEMDABAD AIR with 25 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to United States for Sirolimus?
The average transit time for Sirolimus shipments from India to United States is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Sirolimus trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.4% with demand growth tracking at 24.9%. The route is ranked #2 among India's top Sirolimus export destinations globally.
Q How many suppliers are active on the India to United States Sirolimus route?
There are currently 14 active Indian suppliers exporting Sirolimus to United States. The market is moderately concentrated with ZYDUS LIFESCIENCES LIMITED accounting for 36% of total shipment value.
Q Who are the main importers of Sirolimus from India in United States?
The leading importers of Indian Sirolimus in United States include EVERSANA LIFE SCIENCE SERVICES, ASCEND LABORATORIES,LLC, DR REDDYS LABORATORIES INC, ASCEND LABORATORIES LLC, XX RXXDYSXXABOXXTORXXS IXX. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 28 shipments worth $6.1M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Sirolimus.
- 2.Supplier/Buyer Matching: 14 Indian exporters and 19 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 123 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
123 Verified Shipments
14 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists